CLINICAL TRIALS PROFILE FOR KENALOG IN ORABASE
All Clinical Trials for KENALOG IN ORABASE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02329600 ↗ | Evaluation of Green Tea as Antioxidant Agent in Management of Oral Lichen Planus | Completed | Cairo University | Phase 3 | 2013-06-01 | The study included forty individuals divided into 3 groups. 10 control subjects, 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and 15 oral lichen planus (OLP) patients who were treated with topical corticosteroids and green tea tablets. |
| NCT06910579 ↗ | Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers | RECRUITING | British University In Egypt | PHASE2 | 2025-03-15 | Interventions of both groups: Oxygenated gel Group: 15 patients who used oxygenated gel (Bluem, Wijhe, Netherlands) were trained by the co-investigator (A.H) through real demonstration for topical application of the gel on aphthous ulcers, which entails the application of 1-2 ml of oxygenated gel directly to the ulcer two times per day and this was repeated for 7 days. Triamcinolone acetonide Group: 15 patients were treated with Kenalog in orabase (Triamcinolone acetonide 0.1% oral paste 5g), four times (i.e., at 8 am, 12 noon, 4 pm, and 8 pm) a day for 7 days at intervention group. Patients in both groups were reexamined after treatment at different intervals (day 3, day 5, day 7, and day 10). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for KENALOG IN ORABASE
Condition Name
Clinical Trial Locations for KENALOG IN ORABASE
Clinical Trial Progress for KENALOG IN ORABASE
Clinical Trial Phase
Clinical Trial Sponsors for KENALOG IN ORABASE
Sponsor Name
